3957 POINT EDEN WAY, HAYWARD, CA
Market cap: $1.0B (12/21/2025)
Price: $15.20
Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Election of Directors and Approval of Executive Compensation at Pulse Bioscie...
Investor Presentation
Earnings Release
Announces First Enrollment in the NANOCLAMP AF Study
Pulse Biosciences Presents nPulse™ System Data at EACTS
Material disclosure
Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
Q3
Q2
Q1
Amended Annual Report
FY 2024
Notice of Late Filing for Quarterly Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Additional Securities
Prospectus Filed Pursuant to Rule 424(b)(2)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Amended Schedule 13D - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload